Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
End Of An Accelerated Approval Odyssey: Covis Agrees To Withdraw Makena But Seeks 21-Week ‘Wind-Down’
Mar 07 2023
•
By
Sue Sutter
Covis acknowledges the end of the road for Makena, but seeks a 21-week reprieve. • Source: Shutterstock
More from Post-Marketing Regulation & Studies
More from Product Reviews